Carboplatin is classified as a Platinum-based Drug.
Cisplatin is classified as a Platinum-based Drug. Cisplatin is more commonly known as the brand Platinol.
Cromolyn is classified as a Mast Cell Stabilizer. Cromolyn, an ingredient in the more commonly known brands Crolom, Gastrocrom and Nasalcrom, may be used to treat Connective Tissue Neoplasms.
Dacarbazine is classified as an Alkylating Drug.
Dactinomycin is classified as an Actinomycin. Dactinomycin is more commonly known as the brand Cosmegen.
Etoposide is classified as a Topoisomerase Inhibitor. Etoposide, more commonly known as the brands Etopophos and Toposar, may be used to treat Connective Tissue Neoplasms.
Methotrexate is classified as a Folate Analog Metabolic Inhibitor. Methotrexate is included in 4 brands sold in the US including Otrexup, Rasuvo and Rheumatrex